Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Biologic or vaccine
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 61 - 63 of 63 items.
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
Shortage of Erwinase for Injection and Replacement with UK Labelled Stock
AlertHealth professional risk communication | 2018-02-27
TECENTRIQ (atezolizumab) - Risk of Myocarditis
AlertHealth professional risk communication | 2018-02-14